Form 4: Stryker VP Fink Reports Routine Stock Transactions

Stryker's VP, Chief HR Officer, M Kathryn Fink, reported the acquisition of dividend equivalent shares and the disposition of common stock following the vesting of performance stock units.

Summary

• M Kathryn Fink, VP, Chief HR Officer of Stryker Corp (SYK), reported transactions on March 21, 2026.
• Acquired 150 shares of common stock as dividend equivalents related to vested Performance Stock Units (PSUs) at a price of $0.
• Disposed of 2,064 shares of common stock at a price of $335.67 per share.
• The disposition likely represents shares sold to cover tax obligations upon the vesting of 5,220 performance stock units previously reported on March 11, 2026.
• Following these transactions, Fink directly owns 16,637 shares of common stock.
• Indirectly owns 422 shares via a 401K and 177 shares via the 2023 Mary Fink Living Trust.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction, with the vesting of performance stock units indicating the achievement of company performance goals, which is a positive signal.

Positives

• The vesting of 5,220 Performance Stock Units indicates the satisfaction of performance criteria, reflecting positively on company and executive performance.
• The acquisition of 150 dividend equivalent shares further increases the executive's stake in the company.

Negatives

• The disposition of 2,064 shares, although likely for tax purposes, reduces direct beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, particularly dispositions for tax purposes following equity awards, are common occurrences and generally do not signal a change in management's long-term outlook for the company. The vesting of performance-based awards suggests the company met its internal targets.

Comparison to Industry Standards

• Insider transactions like these are standard practice across industries for executives receiving equity compensation. For example, executives at Medtronic (MDT) or Johnson & Johnson (JNJ) frequently report similar 'sell to cover' transactions upon the vesting of restricted stock units or performance shares, aligning with common executive compensation structures in the medical technology sector.

Stakeholder Impact

• Shareholders: Minor impact, as this is a routine insider transaction. The vesting of Performance Stock Units could be seen as a positive signal regarding company performance and executive alignment.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to executive compensation, specifically the vesting of performance stock units and subsequent sale of shares to cover tax liabilities. Such transactions are common and generally do not indicate a change in the company's fundamental outlook or warrant a change in investment recommendation. The vesting of performance-based awards is a positive sign of goal achievement.

Keywords

Stryker, SYK, Form 4, Insider Trading, Stock Transaction, M Kathryn Fink, Performance Stock Units, Dividend Equivalents, Executive Compensation